COMPARATIVE STUDY TO EVALUATE THE EFFICACY Of SAMASAPTAKA CHOORNA AND AVIPATTIKARA CHOORNA IN AMLAPITTA (GASTRITIS)

A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY Of SAMASAPTAKA CHOORNA AND AVIPATTIKARA CHOORNA IN AMLAPITTA

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037634

Enrollment

Registered

2021-10-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH IN THE AGE GROUP OF 16 YEARS TO 60 YEARS. PATIENTS WILLING TO PARTICIPATE IN THE STUDY AND SIGN INFORMED CONSENT FORM. PATIENTS DIAGNOSED WITH AMLAPITTA. PATIENTS FULFILLING THE DIAGNOSTIC CRITERIA. CHRONICITY LESS THAN 1 YEAR.

Exclusion criteria

Exclusion criteria: PATIENTS WHO DO NOT GIVE WRITTEN CONSENT FOR CLINICAL TRIALS. PATIENTS WITH DRUG INDUCED AMLAPITTA. PATIENTS WITH DIAGNOSED CASES OF GASTRIC, PEPTIC AND DUODENAL ULCERS. PREGNANT WOMEN AND LACTATING MOTHERS. PATIENTS DIAGNOSED WITH MALIGNANCIES. PATIENTS WITH HISTORY OF HAEMATEMESIS. SYSTEMIC DISORDERS WHICH INTERFERS COURSE OF TREATMENT.

Design outcomes

Primary

Measure	Time frame
ASSESSMENT OF THE CONDITION WILL BE DONE BY ADOPTING STANDARD METHOD OF SCORING AND WILL BE ANALYSED STATISTICALLY. SUBJECTIVE PARAMETERS; TIKTA-UDGARA AMLA-UDGARA HRITDAHA KANTADAHA AVIPAKA KLAMA UTKLESHA GOURAVA ARUCHITimepoint: ASSESSMENT OF THE CONDITION WILL BE DONE BY ADOPTING STANDARD METHOD OF SCORING AND WILL BE ANALYSED STATISTICALLY. TIME PERIOD-PATIENT WIL BE OBSERVED BEFORE TREATMENT, AFTER 16TH AND 31ST DAT OF TREATMENT TO ASSESS THE PROGRESS. FOLLOW UP ASSESSMENT WILL BE DONE ON 16TH DAY AFTER THE COURSE OF TREATMENT (46TH DAY ). 15 DAYS FOLLOW UP IS DONE. TOTAL STUDY DURATION INCLUDING FOLLOW UO:45 DAYS	—

Measure

Time frame

ASSESSMENT OF THE CONDITION WILL BE DONE BY ADOPTING STANDARD METHOD OF SCORING AND WILL BE ANALYSED STATISTICALLY. SUBJECTIVE PARAMETERS; TIKTA-UDGARA AMLA-UDGARA HRITDAHA KANTADAHA AVIPAKA KLAMA UTKLESHA GOURAVA ARUCHITimepoint: ASSESSMENT OF THE CONDITION WILL BE DONE BY ADOPTING STANDARD METHOD OF SCORING AND WILL BE ANALYSED STATISTICALLY. TIME PERIOD-PATIENT WIL BE OBSERVED BEFORE TREATMENT, AFTER 16TH AND 31ST DAT OF TREATMENT TO ASSESS THE PROGRESS. FOLLOW UP ASSESSMENT WILL BE DONE ON 16TH DAY AFTER THE COURSE OF TREATMENT (46TH DAY ). 15 DAYS FOLLOW UP IS DONE. TOTAL STUDY DURATION INCLUDING FOLLOW UO:45 DAYS

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR SANJANA PK

ALVAS AYURVEDA MEDICAL COLLEGE AND HOSPITAL MOODBIDRI 574227

shettysusheel13@gmail.com9980431676

Outcome results